English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 
Ultra-high speed Wi-Fi developed for Seoul's subway trains
Feb 08, 2018 19:00 HKT
Sanofi Delivers 2017 Business EPS in line with Guidance
Feb 07, 2018 15:00 HKT
Moving beyond graphene
Feb 01, 2018 19:30 HKT
Aldebaran5, Next Generation Autonomous Vehicle Computing Platform in a Single Chip
Jan 26, 2018 20:30 HKT
Nanobiotix Presents First Promising Data from Phase I/II Liver Cancers Trial of NBTXR3 at the American Society of Clinical Oncology Gastrointestinal Annual Meeting
Jan 22, 2018 15:00 HKT
Sanofi to Acquire Bioverativ for $11.6 Billion
Jan 22, 2018 14:00 HKT
Nanobiotix Partners with Providence Cancer Institute to run Immunotherapeutic Preclinical Research in Pancreatic Cancers
Jan 11, 2018 15:00 HKT
Automatic language interpretation technology to be piloted at Winter Olympics
Jan 08, 2018 11:30 HKT
Nanobiotix: 2017 review and 2018 expected milestones
Dec 26, 2017 15:50 HKT
FDA approves Nanobiotix's first Immuno-Oncology trial
Dec 26, 2017 15:15 HKT
Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3's significant potential role in Immuno-Oncology at SITC Annual Meeting
Nov 13, 2017 15:00 HKT
Nanobiotix provides update on the global development of its lead product NBTXR3
Nov 10, 2017 08:30 HKT
Nanobiotix Completes Patient Inclusion for Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma
Oct 23, 2017 14:00 HKT
Helsinn Pharmaceuticals (Beijing) Co. Ltd. Opens Office in Shanghai, China
Oct 17, 2017 14:30 HKT
Sanofi: Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent(R) (alirocumab)
Oct 06, 2017 08:00 HKT
Nanobiotix plans to conduct its first clinical trial with NBTXR3 in combination with immune checkpoint inhibitors in the U.S.
Sep 29, 2017 08:00 HKT
From iPad to iPaper
Sep 04, 2017 01:00 HKT
Nanobiotix half year results for the six months ended 30 June 2017
Sep 01, 2017 01:30 HKT
Mangroves vital for environmental decontamination
Aug 05, 2017 00:00 HKT
Who learns foreign language better - introverts or extraverts?
Jul 14, 2017 23:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: